Sumavel and Breastfeeding

Research studies have shown that Sumavel (sumatriptan injection) does pass through human breast milk in low amounts. The manufacturer advises that women use this medication with caution while nursing, and some sources recommend avoiding breastfeeding for eight hours after a dose of Sumavel. Before breastfeeding, women should talk to their healthcare provider about the potential risks.

Can Breastfeeding Women Take Sumavel?

Sumavel™ DosePro™ (sumatriptan injection) passes through breast milk in humans. The manufacturer recommends that women use this medication with caution while breastfeeding. Therefore if you are nursing a child, you should talk with your healthcare provider before using Sumavel.

Important Information on Sumavel and Breastfeeding

As previously stated, research has demonstrated that sumatriptan (the active ingredient in Sumavel) passes through breast milk in humans in low amounts. The American Academy of Pediatrics lists this medication as being "compatible with breastfeeding." Although some sources recommend that women avoid breastfeeding for eight hours after a dose of this medication, other sources state that this precaution is probably unnecessary except with premature infants.

Talking With Your Healthcare Provider

You should discuss breastfeeding and Sumavel with your healthcare provider. Each woman's situation is different, and you and your healthcare provider understand your situation best. After considering what you want and expect, as well as your current health situation, the two of you can make a shared decision that is right for you.
5 Common Pain Medication Fears

Sumavel Medication Information

Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2020 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.